GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Celemics Inc (XKRX:331920) » Definitions » Capital Expenditure

Celemics (XKRX:331920) Capital Expenditure : ₩-148.07 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Celemics Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Celemics's cash flow for capital expenditures for the three months ended in Mar. 2024 was ₩-22 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-148.07 Mil.


Celemics Capital Expenditure Historical Data

The historical data trend for Celemics's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celemics Capital Expenditure Chart

Celemics Annual Data
Trend Dec15 Dec16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial -138.12 -421.87 -574.22 -550.87 -219.26

Celemics Quarterly Data
Mar19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -93.33 -14.31 -52.00 -59.61 -22.15

Celemics Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-148.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Celemics (XKRX:331920) Business Description

Traded in Other Exchanges
N/A
Address
131 Gasandigital 1-ro, Geumcheon-gu, 19-20 Floor, Building A, BYC Highcity, Seoul, KOR, 08506
Celemics Inc is a manufacturer of Next Generation Sequencing test kit. It offers, develops and manufactures proprietary DNA and genetic sequencing test kits and panels. Its products include Targeted Sequencing Kit, NGS Library Preparation Kit, and XSEP MagBead.

Celemics (XKRX:331920) Headlines

No Headlines